One of those outcomes could be an abnormally high expression of the aromatase enzyme in the breast, an enzyme that is responsible for the production of increased local estrogen, thus predisposing the mammary tissue to hyperplasia and cancer [18], as well as a bioenergetic adaptation of the cancer cells [48, 49]. This evidence concerns the gene CYP19A1 and cancer.